Some trials are focusing on drugs that target the immune system, which is affected by different pathways to long covid.

SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the ...

While the Trump administration targets COVID-19-related research, a new report from the ECDC shows the benefits of ...

The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials ...

The global pandemic may have officially waned, but for millions around the world, the aftershocks of COVID-19 remain an ...

As public health systems strain and families like Jennifer’s wait for solutions, scientists at Johns Hopkins are working ...

Acute coronary syndrome (ACS) in patients with SARS-CoV-2 infection represents a critical intersection of viral-induced inflammation and ...

Seattle vaccine experts were confused by the country's apparent new direction around updated COVID-19 shots, which top FDA ...

Researchers looked at biomarkers in study participants and found that those complaining of brain fog had higher levels of an ...

Long COVID—clinically known as post-acute sequelae of SARS-CoV-2 infection (PASC)—is a life-altering condition that affects more than 400 million people worldwide. Symptoms can persist for months or ...

Adults who later developed long COVID had lower cardiorespiratory fitness (CRF) before infection than those who did not.